Prelaj, A.
Fondazione IRCCS Istituto Nazionale dei Tumori
6 papers on CoChatORCID 0000-0002-3863-088X
Most cited papers
- Verified
Artificial Intelligence for Predictive Biomarker Discovery in Immuno-Oncology: A Systematic Review
Prelaj, A., Miskovic, V., Zanitti, M., Trovo, F., Genova, C., Viscardi, G., Rebuzzi, S. E., Mazzeo, L., Provenzano, L., Kosta, S., et al. (2024) · Annals of Oncology
Cancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical Imaging
Cited by 340
- Verified
ESMO guidance for reporting oncology real-world evidence (GROW)
Castelo-Branco, L., Pellat, A., Martins-Branco, D., Valachis, A., Derksen, J. W. G., Suijkerbuijk, K. P. M., Dafni, U., Dellaporta, T., Vogel, A., Prelaj, A., et al. (2023) · Annals of Oncology
Meta-analysis and systematic reviewsClinical practice guidelines implementation
Cited by 247
- Verified
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
Le, X., Kim, T. M., Loong, H. H., Prelaj, A., Goh, B. C., Li, L., Fang, Y., Lu, S., Dong, X., Wu, L., et al. (2025) · New England Journal of Medicine
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 70
- Verified
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
Passaro, A., Prelaj, A., Bonanno, L., Tiseo, M., Tuzi, A., Proto, C., Chiari, R., Rocco, D., Genova, C., Sini, C., et al. (2019) · Clinical Lung Cancer
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 54
- Verified
ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP)
Wong, E. Y. T., Verlingue, L., Aldea, M., Franzoi, M. A., Umeton, R., Halabi, S., Harbeck, N., Indini, A., Prelaj, A., Romano, E., et al. (2025) · Annals of Oncology
Artificial Intelligence in Healthcare and EducationElectronic Health Records Systems
Cited by 44
- Verified
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
Prelaj, A., Galli, E. G., Miskovic, V., Pesenti, M., Viscardi, G., Pedica, B., Mazzeo, L., Bottiglieri, A., Provenzano, L., Spagnoletti, A., et al. (2023) · Frontiers in Oncology
Cancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical Imaging
Cited by 39
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free